(Q39872573)

15 September 2017

title

Drug-susceptibility testing in TB: current status and future prospects (English)

1 reference

15 September 2017

2

Sabine Rüsch-Gerdes

1 reference

15 September 2017

Elvira Richter

1

1 reference

15 September 2017

Doris Hillemann

series ordinal

3

1 reference

15 September 2017

publication date

1 October 2009

1 reference

Expert Review of Respiratory Medicine

15 September 2017

published in

1 reference

15 September 2017

volume

3

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

497-510

1 reference

Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis

15 September 2017

cites work

1 reference

Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method

21 January 2018

1 reference

Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system

21 January 2018

1 reference

Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy

21 January 2018

1 reference

Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test

21 January 2018

1 reference

Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion

21 January 2018

1 reference

Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method

21 January 2018

1 reference

Evaluation of indirect susceptibility testing of Mycobacterium tuberculosis to the first- and second-line, and alternative drugs by the newer MB/BacT system

21 January 2018

1 reference

Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis

21 January 2018

1 reference

Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials

21 January 2018

1 reference

Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system

21 January 2018

1 reference

Drug resistance in tuberculosis

21 January 2018

1 reference

Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide

21 January 2018

1 reference

Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis

21 January 2018

1 reference

Direct colorimetric assay for rapid detection of rifampin-resistant Mycobacterium tuberculosis.

21 January 2018

1 reference

Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

Evaluation of rapid MTT tube method for detection of drug susceptibility of Mycobacterium tuberculosis to rifampicin and isoniazid

21 January 2018

1 reference

Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

21 January 2018

1 reference

Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings

21 January 2018

1 reference

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

21 January 2018

1 reference

Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance

21 January 2018

1 reference

Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis

21 January 2018

1 reference

Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay

21 January 2018

1 reference

The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples

21 January 2018

1 reference

Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples

21 January 2018

1 reference

Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis.

21 January 2018

1 reference

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis

21 January 2018

1 reference

Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

21 January 2018

1 reference

Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literature

21 January 2018

1 reference

Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy

21 January 2018

1 reference

Oxidation of isoniazid by manganese and Mycobacterium tuberculosis catalase-peroxidase yields a new mechanism of activation

21 January 2018

1 reference

The mechanism of isoniazid killing: clarity through the scope of genetics

21 January 2018

1 reference

Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing

21 January 2018

1 reference

Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.

21 January 2018

1 reference

Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates

21 January 2018

1 reference

The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol

21 January 2018

1 reference

Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol

21 January 2018

1 reference

Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates

21 January 2018

1 reference

Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin

21 January 2018

1 reference

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

21 January 2018

1 reference

Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

21 January 2018

1 reference

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

21 January 2018

1 reference

ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates

21 January 2018

1 reference

Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates

21 January 2018

1 reference

Rapid detection of specific gene mutations associated with isoniazid or rifampicin resistance in Mycobacterium tuberculosis clinical isolates using non-fluorescent low-density DNA microarrays.

21 January 2018

1 reference

Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis.

21 January 2018

1 reference

In house reverse line hybridization assay for rapid detection of susceptibility to rifampicin in isolates of Mycobacterium tuberculosis.

21 January 2018

1 reference

Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis

21 January 2018

1 reference

Development and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains

21 January 2018

1 reference

Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens

21 January 2018

1 reference

Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates

21 January 2018

1 reference

Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy

21 January 2018

1 reference

Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay.

21 January 2018

1 reference

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.09.45

1 reference

15 September 2017

1 reference